MeSH D007010 - hyponatremia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Tolvaptan | Tolvaptan Accord |  |  |  |  |
| Alkem Laboratories | Tolvaptan | Tolvaptan |  | 2020-05-19 |  |  |
| Apotex | Tolvaptan | Tolvaptan |  | 2020-05-19 |  |  |
| Baxter | Dextrose, Sodium chloride, Sodium lactate | Dianeal |  | 1992-12-04 |  |  |
| Dextrose, Sodium chloride, Sodium lactate | Dianeal W/dextrose |  | 1982-01-01 |  |  | |
| Sodium chloride, Sodium bicarbonate | Phoxillum B22k |  | 2015-01-13 |  |  | |
| Dextrose, Lactic acid, Sodium chloride, Sodium bicarbonate | Prismasol |  | 2006-10-25 |  |  | |
| Cumberland Pharmaceuticals | Conivaptan | Vaprisol |  | 2005-12-29 | $-0.147 M | Q4/22-Q1/24 |
| Endo | Tolvaptan | Tolvaptan |  | 2022-02-15 |  |  |
| Hetero | Tolvaptan | Tolvaptan |  | 2021-07-16 |  |  |
| Lupin Research | Tolvaptan | Tolvaptan |  | 2025-04-23 |  |  |
| MSN Laboratories | Tolvaptan | Tolvaptan |  | 2023-06-21 |  |  |
| Nostrum Laboratories | Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate | Peg, Potassium Chloride, Bicarbonate, |  | 2017-03-08 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
100%4/4
Phase 3
40%6/15
Approved: 2Overall Success rate: 40%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use